BioSpace News Archive

Business

Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare

Such a deep, data-driven approach is enabling precision medicine, in particular, which is expanding from oncology to autoimmune diseases and other conditions.

January 20, 2022
·
5 min read
·
Gail Dutton
Career Advice

Successfully Compete for Jobs in a Crowded Remote Work Talent Pool

With more and more people applying for remote positions, how can you stand out among the massive stacks of applications?

January 20, 2022
·
3 min read
·
Hannah Harshman
Drug Development

COVID-19 Brief: Vaccinations for 5 and Under Coming as Omicron Proves More Dangerous

Dr. Anthony Fauci expects the FDA will authorize the Pfizer-BioNTech vaccine for children under the age of five in the next month.

January 20, 2022
·
6 min read
·
Mark Terry
Business

Tennis Star Bets on a Grand Slam as 80% Shareholder in Danish Biotech

World tennis superstar Novak Djokovic reportedly has an 80% stake in QuantBioRes that’s currently working on finding a treatment, not a vaccine, for COVID-19.

January 20, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Psychedelic Biotech Takes SPAC Track to Nasdaq

Psychedelic-focused drug company Eleusis is merging with Silver Spike Acquisition Corp. II, a special purposes acquisition company, and heading to the Nasdaq with a combined enterprise value of $446 million.

January 20, 2022
·
2 min read
·
Alex Keown
Deals

Unilever Throws in the Towel on GSK Business Buy after Rejection

Unilever announced Wednesday that it will not increase its bid over the recently proposed £50 billion (about $68 billion) to ensure that the acquisitions create value for its shareholders.

January 20, 2022
·
2 min read
·
Alex Keown
Business

Cancer Biotech Boosts Funding and Names New CEO

The funds will be used to advance the firm’s precision oncology research efforts and pipeline, particularly those involving the creation of alteration-specific therapies.

January 20, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

ImmPACT Bio Gains $111M, a New Leader and Positive Trial Results

ImmPACT Bio provided an optimistic update on a Phase I clinical study evaluating its CD19-CD20 bi-specific Chimeric Antigen Receptor T-cell (CAR-T) therapy.

January 20, 2022
·
3 min read
·
Hayley Shasteen
BioMidwest

Research Roundup: Nanotherapy and Islet Transplants for Diabetes and More

For about a century, the way to treat Type 1 diabetes has been via insulin injections. Although research has been conducted on pancreatic islet transplants, it’s a tough nut to crack in terms of organ rejection. There’s been a potential breakthrough in that area involving nanotherapy.

January 20, 2022
·
5 min read
·
Mark Terry
Drug Development

The Pipeline Gets the Cash as Zymeworks Trims 25% of Staff

As part of a company-wide workforce reduction, it will cut its employee headcount by at least 25% by the end of the year, and 50% of its senior management team are leaving the company.

January 20, 2022
·
2 min read
·
Mark Terry